Clinical Trials - Phase III

Filter News

Found 22,101 articles

Vasogen's Phase III SIMPADICO Results To Be Presented At Late-Breaking Session Of The 55th Annual Scientific Session Of The American College of Cardiology

2/1/2006
Pharmexa A/S Files The First Phase III Application

2/1/2006
Alfacell Drug Trial Ahead of Schedule; Revises Guidance On Patient Enrollment For The ONCONASE Confirmatory Phase IIIb Clinical Trial In Unresectable Malignant Mesothelioma

1/30/2006
Inspire Pharmaceuticals Release: Denufosol Proceeding To Phase 3 Trials In Cystic Fibrosis

1/30/2006
Icagen, Inc.'s Phase III Clinical Trial Of ICA-17043 On Course Following Planned Safety Review

1/30/2006
Favrille, Inc. Completes Patient Enrollment In Pivotal Phase 3 Clinical Trial Of FavId For Follicular B-Cell Non-Hodgkin's Lymphoma

1/30/2006
Icagen, Inc.'s Phase III Clinical Trial Of ICA-17043 On Course Following Planned Safety Review

1/27/2006
Alexion Pharmaceuticals Inc. Reports Positive Results For Phase 3 Blood Treatment

1/26/2006
Clinical Data Initiates Pivotal Phase III Trial For Novel Antidepressant

1/26/2006
Point Therapeutics Announces Time Change For January 31, 2006 Webcast; Webcast On Phase 3 NSCLC Program And Clinical Update Moved To 8:30 AM EST

1/26/2006
Nuvelo, Inc. Blood Clot Drug Gets Fast-Tracked

1/23/2006
MIGENIX Inc. To Initiate MX-3253 HCV Viral Kinetics Study In Treatment Naive Patients; CEO Message No. 17 Released

1/23/2006
SuperGen, Inc. Announces Withdrawal Of Orathecin(TM) Marketing Authorization Application

1/20/2006
Point Therapeutics To Host Webcast On January 31, 2006 Webcast To Present Phase 3 NSCLC Program And Clinical Update

1/20/2006
DOR BioPharma, Inc. Reports Positive New Survival Findings From Previously Completed Phase II And III Clinical Trials Of orBec(R)

1/20/2006
Gentium S.p.A. Initiates Phase II/III Pediatric Trial With Defibrotide To Prevent Veno-Occlusive Disease

1/20/2006
Dynavax Technologies Corporation Says Allergy Drug Meets Goal Of Phase 2/3 Trial

1/19/2006
Novartis Corporation New Phase III Data With SPP100 Reconfirms Strong Efficacy And Excellent Safety Profile As Monotherapy And Co-Administration Therapy For Treatment Of Hypertension

1/19/2006
GTx, Inc. To Continue With Pivotal Studies Of Acapodene

1/19/2006
Genentech, Inc. Release: Preliminary Phase III Data From Head-To-Head Study Of Lucentis Shows Lucentis Improved Vision Compared To Visudyne In Patients With Wet Age-Related Macular Degeneration

1/16/2006